OGEN
Income statement / Annual
Last year (2023), Oragenics, Inc.'s total revenue was $37,653.00,
a decrease of 71.37% from the previous year.
In 2023, Oragenics, Inc.'s net income was -$20.66 M.
See Oragenics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$37,653.00
|
$131,521.00
|
$86,987.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.18 M
|
$939,926.00
|
| Cost of Revenue |
$15.49 M |
$44,667.00 |
$41,237.00 |
$51,705.00 |
$62,622.00 |
$30,110.00 |
$65,803.00 |
$75,044.00 |
$481,743.00 |
$369,597.00 |
| Gross Profit |
-$15.45 M |
$86,854.00 |
$45,750.00 |
-$51,705.00 |
-$62,622.00 |
-$30,110.00 |
-$65,803.00 |
-$75,044.00 |
$694,098.00 |
$570,329.00 |
| Gross Profit Ratio |
-410.4 |
0.66 |
0.53 |
0 |
0 |
0 |
0 |
0 |
0.59 |
0.61 |
| Research and Development
Expenses |
$15.49 M
|
$10.07 M
|
$10.59 M
|
$22.11 M
|
$12.12 M
|
$5.97 M
|
$3.54 M
|
$4.75 M
|
$8.80 M
|
$3.07 M
|
| General & Administrative
Expenses |
$5.45 M
|
$4.47 M
|
$5.27 M
|
$4.53 M
|
$3.76 M
|
$4.02 M
|
$3.18 M
|
$3.79 M
|
$3.54 M
|
$3.32 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$61,085.00
|
| Selling, General &
Administrative Expenses |
$5.45 M
|
$4.47 M
|
$5.27 M
|
$4.53 M
|
$3.76 M
|
$4.02 M
|
$3.18 M
|
$3.79 M
|
$3.54 M
|
$3.32 M
|
| Other Expenses |
-$15.49 M |
$5,140.00 |
$1,357.00 |
$2,400.00 |
$1,601.00 |
$446.00 |
-$3,100.00 |
-$4,800.00 |
-$4,700.00 |
$0.00 |
| Operating Expenses |
$5.45 M |
$14.55 M |
$15.86 M |
$26.64 M |
$15.88 M |
$10.00 M |
$6.72 M |
$8.54 M |
$12.35 M |
$6.39 M |
| Cost And Expenses |
$20.94 M |
$14.55 M |
$15.86 M |
$26.64 M |
$15.88 M |
$10.00 M |
$6.72 M |
$8.54 M |
$12.83 M |
$6.76 M |
| Interest Income |
$179,803.00 |
$135,900.00 |
$75,847.00 |
$89,294.00 |
$320,011.00 |
$86,527.00 |
$10,221.00 |
$40,090.00 |
$21,378.00 |
$36,998.00 |
| Interest Expense |
$0.00 |
$15,103.00 |
$15,756.00 |
$10,685.00 |
$7,300.00 |
$5,786.00 |
$216,328.00 |
$4,116.00 |
$76,668.00 |
$4,030.00 |
| Depreciation &
Amortization |
$27,391.00
|
$44,667.00
|
$41,237.00
|
$51,705.00
|
$62,622.00
|
$30,110.00
|
$65,803.00
|
$75,044.00
|
$71,152.00
|
$27,667.00
|
| EBITDA |
-$20.88 M
|
-$14.23 M
|
-$15.65 M
|
-$26.37 M
|
-$15.50 M
|
-$9.88 M
|
-$6.45 M
|
-$8.42 M
|
-$11.65 M
|
-$5.76 M
|
| EBITDA Ratio |
-554.47 |
-108.19 |
-179.97 |
0 |
0 |
0 |
0 |
0 |
-9.83 |
-6.12 |
| Operating Income Ratio
|
-555.2
|
-109.61
|
-181.3
|
0
|
0
|
0
|
0
|
0
|
-9.91
|
-6.19
|
| Total Other
Income/Expenses Net |
$249,166.00
|
$127,239.00
|
$59,404.00
|
$210,757.00
|
$311,566.00
|
$79,999.00
|
-$13,207.00
|
$45,189.00
|
-$59,214.00
|
$26,976.00
|
| Income Before Tax |
-$20.66 M |
-$14.29 M |
-$15.71 M |
-$26.43 M |
-$15.57 M |
-$9.91 M |
-$6.73 M |
-$8.50 M |
-$11.71 M |
-$5.79 M |
| Income Before Tax Ratio
|
-548.58
|
-108.64
|
-180.62
|
0
|
0
|
0
|
0
|
0
|
-9.96
|
-6.16
|
| Income Tax Expense |
$0.00 |
-$127,239.00 |
$16,426.00 |
$12,480.00 |
$7,756.00 |
-$79,999.00 |
$13,207.00 |
-$1.53 M |
$59,214.00 |
-$26,976.00 |
| Net Income |
-$20.66 M |
-$14.16 M |
-$15.73 M |
-$26.44 M |
-$15.57 M |
-$9.91 M |
-$6.73 M |
-$7.01 M |
-$11.71 M |
-$5.79 M |
| Net Income Ratio |
-548.58 |
-107.67 |
-180.81 |
0 |
0 |
0 |
0 |
0 |
-9.96 |
-6.16 |
| EPS |
-9.18 |
-7.05 |
-8.36 |
-28.07 |
-22.1 |
-45.62 |
-81.99 |
-94.35 |
-191.7 |
-96.08 |
| EPS Diluted |
-9.18 |
-7.05 |
-8.36 |
-28.07 |
-22.1 |
-45.62 |
-81.99 |
-94.33 |
-191.7 |
-96.08 |
| Weighted Average Shares
Out |
$2.25 M
|
$2.01 M
|
$1.88 M
|
$942,187.00
|
$704,732.00
|
$217,318.00
|
$82,104.00
|
$74,333.00
|
$61,093.00
|
$60,255.00
|
| Weighted Average Shares
Out Diluted |
$2.25 M
|
$2.01 M
|
$1.88 M
|
$942,187.00
|
$704,732.00
|
$217,318.00
|
$82,104.00
|
$74,348.00
|
$61,093.00
|
$60,255.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
